Curium US LLC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$774Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
282clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $211K
2020 $266K
2021 $186K
2022 $16K
2023 $19K
2024 $46K
2025 $30K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Hospitalist $543K
Medical Oncology $75K
Nuclear Medicine $42K
Nuclear Radiology $31K
Surgical Oncology $22K
Diagnostic Radiology $14K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Odulola Odusanya Libertyville, IL Hospitalist $543,160.00
Thomas Hope San Francisco, CA Nuclear Radiology $31,198.91
Erik Mittra Portland, OR Nuclear Medicine $22,261.31
Eric Liu Denver, CO Surgical Oncology $22,079.13
Robert Ramirez Nashville, TN Medical Oncology $14,104.86
Aman Chauhan San Francisco, CA Medical Oncology $11,899.26
Vikas Prasad Saint Louis, MO Nuclear Medicine $10,298.59
Lowell Anthony Lexington, KY Medical Oncology $10,228.95
Thorvardur Halfdanarson Rochester, MN Medical Oncology $9,683.87
Gary Ulaner Los Angeles, CA Diagnostic Radiology $7,737.04

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.